Technical Papers

265 Results

Oracle

Accelerating Data Cleaning, Integration & Analysis

Oracle Health Sciences | 01-Nov-2015 | Technical / White Paper

The new white paper, “Accelerating Data Cleaning, Integration & Analysis from Source to Submission,” examines how Oracle Health Sciences Data Management...

Tactical strategies for healthcare M&A success

Tactical strategies for healthcare M&A success

UPS UK | 28-Oct-2015 | Technical / White Paper

At UPS, our core business is helping companies manage change. We’ve worked with lots of healthcare companies during M&A transitions and have identified...

Mpi_Research

MPI Research Going Further For You

MPI Research | 12-Oct-2015 | Research Study

The best way to support our troops is to help them come home healthy. Over 52,280 United States service members were wounded in action during the conflicts...

Tailor-made solutions for the healthcare industry

Tailor-made solutions for the healthcare industry

B. Braun Melsungen AG | 29-Sep-2015 | Technical / White Paper

B. Braun OEM offers standard products or customized versions. Even the standard range contains hundreds of product versions, with which countless applications...

Single-Use Practices for Cleanroom Fluid Transfer

Single-Use Practices for Cleanroom Fluid Transfer

AdvantaPure® | 21-Sep-2015 | Technical / White Paper

Pharmaceutical and biopharma manufacturers must transfer fluids from room to room quickly with maximum productivity and minimal effort and expense. By...

Article on Viral Clearance for Biopharmaceuticals

Article on Viral Clearance for Biopharmaceuticals

Catalent Pharma Solutions | 31-Aug-2015 | Technical / White Paper

Viral clearance studies are mandated prior to entering clinical trials and for commercial launch of biopharmaceuticals.  These studies are a key component...

Next-Generation Orphan Drug Delivery Ebook

Next-Generation Orphan Drug Delivery Ebook

Catalent Pharma Solutions | 31-Aug-2015 | Technical / White Paper

According to the National Organization for Rare Disorders (NORD), a disease is rare if it affects fewer than 200,000 Americans. Big Pharma used to ignore...